Hydromorphone With Electroacupuncture and Ear Acupoint Pressing for Refractory Cancer Pain (NCT07489625) | Clinical Trial Compass
Not Yet RecruitingEarly Phase 1
Hydromorphone With Electroacupuncture and Ear Acupoint Pressing for Refractory Cancer Pain
China30 participantsStarted 2026-03-07
Plain-language summary
This trial aims to address refractory cancer pain (RCP). It will explore the synergistic efficacy and safety of hydromorphone hydrochloride sustained-release tablets (HHST) combined with electroacupuncture (EA) and ear acupoint pressing beans (EAPB) for RCP. Key outcomes will include dynamic changes in Numerical Rating Scale (NRS) scores, proportions of patients with effective analgesia (≥30% NRS reduction from baseline) and marked remission (≥50% NRS reduction from baseline), daily HHST dosage, breakthrough pain (BP) frequency, and drug-related adverse events (AEs) graded by CTCAE 5.0.
Who can participate
Age range19 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Patients who meet the diagnostic criteria for cancer ;
✓. Diagnosis of refractory cancer pain;
✓. Aged 19 or 80 years;
✓. Expected survival period ≥3 months;
✓. Karnofsky Performance Status (KPS) score ≥30 and Quality of Life (QOL) score ≥20;
✓. No history of allergy to opioid analgesics;
✓. No intellectual or psychiatric disorders; normal comprehension ability,capable of cooperating with pain assessments and questionnaire completion;
✓. Provision of signed written informed consent.
Exclusion criteria
✕. Patients with pain clearly unrelated to the tumor itself;
✕. Patients with pain relief after standardized pharmacological treatment;
What they're measuring
1
Comparison of changes in Numerical Rating Scale (NRS) pain score between baseline and post-treatment.
✕. Patients with an expected survival of less than 3 months;
✕. Patients with a Karnofsky Performance Status (KPS) score \< 30 or Quality of Life (QOL) score \< 20;
✕. Pregnant or lactating women;
✕. Patients with intellectual disability, mental or consciousness disturbance, who are unable to assess pain accurately or complete questionnaire surveys;
✕. Patients with needle phobia or extreme resistance to acupuncture treatment;